If you or a loved one is battling treatment-resistant depression, the search for relief often comes with a pressing question: how much does esketamine nasal spray cost in 2026? As the landscape of mental health treatment evolves, understanding the financial commitment for innovative therapies like Spravato (the brand name for esketamine) is just as important as understanding the clinical benefits. This guide breaks down the latest 2026 pricing, hidden costs, and strategies to make this life-changing treatment more accessible.
The Sticker Price: What We Know for 2026
First, the raw numbers. The cost of esketamine nasal spray isn’t a single, simple figure; it varies by country and depends on whether you are paying out-of-pocket or using insurance.
In the United States, the conversation around pricing has been ongoing. While a 2019 analysis by the Institute for Clinical and Economic Review (ICER) suggested a wholesale acquisition cost of $295 per 28 mg device, the reality for patients in 2026 is often higher due to facility fees and supervision . However, new data from Europe gives us a concrete look at 2026 rate adjustments:
- In the UK, the Oxford Health NHS Foundation Trust has set its self-pay rates for April 2026 at £591 for a 56mg dose and £754 for an 84mg dose .
- In Germany, healthcare forums discussing hospital reimbursement have confirmed a negotiated price of €196.35 per 28mg spray for 2026 .
The Real “In-Clinic” Cost: It’s More Than Just the Spray
It is crucial to understand that esketamine nasal spray is not a take-home prescription. Due to FDA regulations and the Risk Evaluation and Mitigation Strategy (REMS) program, it must be administered in a certified healthcare setting where medical professionals can monitor you for at least two hours for side effects like dissociation or changes in blood pressure .
This means your total bill is a package deal. For patients in the U.S. paying without insurance, this translates to a significant figure. Industry estimates for 2026 suggest that a single treatment session can range from $700 to $1,200 . This total usually comprises:
- The Medication: The nasal spray itself.
- The Facility Fee: The cost of using the clinic’s certified space.
- The Supervision Fee: The cost of healthcare providers monitoring you during the two-hour observation period .
Breaking Down the 2026 Treatment Journey
To truly grasp the cost, you have to look at the treatment protocol. The first month (the “induction phase”) is the most intense, requiring two visits per week.
- Month 1 (Induction): 8 sessions. Estimated out-of-pocket total: $5,600 to $9,600 .
- Month 2 (Transition): 4 weekly sessions. Estimated total: $2,800 to $4,800 .
- Maintenance: 1-2 times per month. Estimated monthly cost: $700 to $2,400 .
How Insurance Changes the Game in 2026
The good news is that because Spravato is FDA-approved, it is covered by many insurance plans—but it requires legwork. Most major insurers, including Aetna, Cigna, UnitedHealthcare, and Medicare Part B, cover esketamine for treatment-resistant depression (TRD) or major depressive disorder (MDD) with suicidal ideation .
However, accessing that coverage in 2026 involves a strict “prior authorization” process. Insurers like Aetna require proof that you have tried and failed at least two different oral antidepressants from different classes at adequate doses .
If you have insurance, your out-of-pocket costs drop dramatically but vary by plan:
